Hims & Hers Health, Inc. (HIMS) Total Return CAGR:-51.73%(TTM)
Over the latest trailing 12-month period, Hims & Hers Health, Inc. (HIMS)'s total return cagr is -51.73%. The comparable SPY value is +22.75%. Year-to-date total return is -14.38%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, Hims & Hers Health, Inc.'s Total Return CAGR averages 45.52% over 3 years and 17.89% over 5 years. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of Hims & Hers Health, Inc.'s investment performance.
HIMS Total Return CAGR Chart
Hims & Hers Health, Inc. (HIMS)
HIMS Quarterly Total Return (YoY)
Total Return Index growth vs the same quarter one year earlier, last 20 quarters.
HIMS Total Return CAGR History
| Year | Start Total Return | End Total Return | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 331.33 | 283.67 | -47.65 | -14.38% | -14.38% |
| 2025 | 246.73 | 331.33 | +84.59 | +34.28% | +34.28% |
| 2024 | 90.82 | 246.73 | +155.92 | +171.69% | +171.69% |
| 2023 | 65.41 | 90.82 | +25.41 | +38.85% | +38.85% |
| 2022 | 66.84 | 65.41 | -1.43 | -2.14% | -2.14% |
| 2021 | 148.98 | 66.84 | -82.14 | -55.14% | -55.14% |
| 2020 | 101.02 | 148.98 | +47.96 | +47.47% | +47.47% |
Quarterly Total Return: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 284 | +33.9% | -43.7% |
| Q1 2026 | 212 | -37.2% | -28.8% |
| Q4 2025 | 337 | -44.1% | +31.3% |
| Q3 2025 | 603 | +19.7% | +232.7% |
| Q2 2025 | 504 | +69.6% | +146.8% |
| Q1 2025 | 297 | +15.8% | +88.4% |
| Q4 2024 | 257 | +41.6% | +178.7% |
| Q3 2024 | 181 | -11.2% | +182.5% |
| Q2 2024 | 204 | +29.4% | +120.2% |
| Q1 2024 | 158 | +71.3% | +56.1% |
| Q4 2023 | 92 | +43.6% | +41.5% |
| Q3 2023 | 64 | -30.8% | +12.7% |
| Q2 2023 | 93 | -8.3% | +100.7% |
| Q1 2023 | 101 | +55.3% | +85.9% |
| Q4 2022 | 65 | +14.3% | -2.6% |
| Q3 2022 | 57 | +23.2% | -26.0% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum